Allarity Therapeutics, Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported net loss was USD 16.06 million compared to USD 26.65 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6275 USD | -1.80% | -21.17% | -94.31% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-94.31% | 197K | |
+9.58% | 115B | |
+12.41% | 106B | |
-2.59% | 21.96B | |
-12.38% | 21.87B | |
-5.29% | 19.21B | |
-3.35% | 18.08B | |
-38.57% | 17.71B | |
+7.51% | 14.32B | |
+35.67% | 12.42B |
- Stock Market
- Equities
- ALLR Stock
- News Allarity Therapeutics, Inc.
- Allarity Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022